STUDY OF THE HYPOGLYCEMIC AND CARDIOPROTECTIVE EFFECT OF EMPAGLIFLOZIN IN THERAPY OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. (2023). World Bulletin of Public Health, 18, 9-14. https://scholarexpress.net/index.php/wbph/article/view/1965